Secukinumab induction and maintenance therapy in moderate-to-severe plaque psoriasis: A randomized, double-blind, placebo-controlled, phase II regimen-finding study

Phoebe Rich*, B. Sigurgeirsson, D. Thaci, J. P. Ortonne, C. Paul, R. E. Schopf, A. Morita, K. Roseau, E. Harfst, A. Guettner, M. MacHacek, C. Papavassilis

*Corresponding author for this work
    214 Citations (Scopus)

    Fingerprint

    Dive into the research topics of 'Secukinumab induction and maintenance therapy in moderate-to-severe plaque psoriasis: A randomized, double-blind, placebo-controlled, phase II regimen-finding study'. Together they form a unique fingerprint.

    Medicine & Life Sciences